The Effects of Gender Affirming Hormone Treatment on Transgender Women’s Musculoskeletal Health: A Systematic Review and Meta-Analysis
Preprint
Abstract
Background: Gender-affirming hormone treatment (GAHT) aligns transgender women’s hormone profiles with their gender identity, alleviating gender dysphoria by inducing feminising changes. However, the effects of GAHT on musculoskeletal health, particularly bone mineral density (BMD), require ongoing evaluation. A previous meta-analysis showed GAHT had a small effect on lumbar spine (LS) BMD, but more recent studies and updated methodologies justify a new synthesis. Methods: A systematic review and meta-analysis were conducted using studies published in English up to 31/07/2024, identified via three electronic databases, cross-referencing, and expert review. Primary outcomes were changes in femoral neck (FN), LS, and total hip (TH) BMD. Secondary outcomes included changes in body composition. Standardised effect sizes (Hedges’ g) were pooled using the inverse heterogeneity (IVhet) model. Results: GAHT was associated with a significant increase in FN BMD (g = 0.13 [0.05, 0.20], p = 0.00). Significant gains were also observed in fat mass (FM) (g = 0.52), BMI (g = 0.16), and body fat percentage (BF%) (g = 0.79), while reductions were found in fat-free mass (FFM) (g = -0.21) and thigh muscle cross-sectional area (mCSA) (g = -1.02). Conclusion: GAHT maintains FN BMD in transgender women with increased FM and reduced fat-free mass. The heterogeneous nature of several outcomes and the absence of empirical data on ageing transgender women require further research and clinical monitoring of bone health (such as High-resolution peripheral quantitative computed tomography) and muscle health to clarify the long-term implications of GAHT, particularly as transgender women age.Keywords
This publication has 83 references indexed in Scilit:
- Bone Mineral Density in Transgender Adolescents Treated With Puberty Suppression and Subsequent Gender-Affirming HormonesJAMA Pediatrics, 2023
- Fracture Risk in Trans Women and Trans Men Using Long-Term Gender-Affirming Hormonal Treatment: A Nationwide Cohort StudyJournal of Bone and Mineral Research, 2019
- Gender-Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older TransmenJournal of Bone and Mineral Research, 2019
- Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and TransmenJournal of Bone and Mineral Research, 2018
- Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational StudyJournal of Bone and Mineral Research, 2017
- Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescentsBone, 2017
- Sport and Transgender People: A Systematic Review of the Literature Relating to Sport Participation and Competitive Sport PoliciesSports Medicine, 2016
- Gender Identities and Gender Dysphoria in the NetherlandsArchives of Sexual Behavior, 2013
- Skeletal Site-Dependent Expression of the Androgen Receptor in Human Osteoblastic Cell PopulationsCalcified Tissue International, 1997
- Variance imputation for overviews of clinical trials with continuous responseJournal of Clinical Epidemiology, 1992